Claims Data Reveals Patients at Post-Op Infection Risk

Share this content:
Claims Data Reveals Patients at Post-Op Infection Risk
Claims Data Reveals Patients at Post-Op Infection Risk

(HealthDay News) – Claims data can be used to accurately identify rates and risk factors for surgical site infection (SSI) following spinal surgery.

Amir Abdul-Jabbar, from University of California in San Francisco, and colleagues investigated the accuracy of an automated approach to administrative claims data to evaluate the rate and risk factors for SSI in spinal surgeries performed from July 2005–December 2010. Surgeries were identified using diagnosis-related group, current procedural terminology, and validated International Classification of Diseases, Ninth Revision codes.

Of the 6,628 hospital visits identified the researchers found that the cumulative incidence of SSI was 2.9%. The rates of infection were significantly increased by procedural risk factors, including sacral involvement (9.6%); fusions greater than seven levels (7.8%); fusions greater than 12 levels (10.4%); cases with an osteotomy (6.5%); operations lasting longer than five hours (5.1%); and transfusions of red blood cells (5.0%), serum (7.4%), and autologous blood (4.1%). Additionally, patient-based risk factors that increased the infection rate included anemia (4.3%), diabetes mellitus (4.2%), coronary artery disease (4.7%), diagnosis of coagulopathy (7.8%), and bone or connective tissue neoplasm (5.0%).

"Using an algorithm combining all three coding systems to generate both inclusion and exclusion criteria, we were able to analyze a specific population of spinal surgery patients within a high-volume medical center," the authors write. "Within that group, risk factors found to increase infection rates were isolated and can serve to focus hospital-wide efforts to decrease surgery-related morbidity and improve patient outcomes."

Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs